Hydrochloric Acid → (2S)-N-{(1R)-2-cyclobutyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl}-2-{[(6-phenoxypyridin-3-yl)sulfonyl]amino}-3-phenylpropanamide
Reaction equation
[NH2:1][C@@H:2]([CH2:25][C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1)[C:3]([NH:5][C@H:6]([B:12]1[O:16][C@@H:15]2[CH2:17][C@@H:18]3[CH2:21][C@H:20]([C@:14]2([CH3:24])[O:13]1)[C:19]3([CH3:23])[CH3:22])[CH2:7][CH:8]1[CH2:11][CH2:10][CH2:9]1)=[O:4].Cl.C(N(CC)C(C)C)(C)C.[O:42]([C:49]1[N:54]=[CH:53][C:52]([S:55](Cl)(=[O:57])=[O:56])=[CH:51][CH:50]=1)[C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1>C1COCC1>[CH:8]1([CH2:7][C@H:6]([NH:5][C:3](=[O:4])[C@@H:2]([NH:1][S:55]([C:52]2[CH:53]=[N:54][C:49]([O:42][C:43]3[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=3)=[CH:50][CH:51]=2)(=[O:56])=[O:57])[CH2:25][C:26]2[CH:27]=[CH:28][CH:29]=[CH:30][CH:31]=2)[B:12]2[O:16][C@@H:15]3[CH2:17][C@@H:18]4[CH2:21][C@H:20]([C@:14]3([CH3:24])[O:13]2)[C:19]4([CH3:23])[CH3:22])[CH2:11][CH2:10][CH2:9]1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Into a 20 mL vial was added (2S)-2-amino-N-{(1R)-2-cyclobutyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl}-3-phenylpropanamide.HCl (46.3 mg, 0.109 mmol) (prepared as described in Example, THF (1.47 mL), N,N diisopropylethylamine (47.5 μL), and 6-phenoxy-3-pyridine sulfonyl chloride (32.4 mg.) The mixture was stirred at room temperature overnight. The product was purified by preparative TLC on silica plates using 50% ethyl acetate in hexanes to give 35 mg desired product as a white solid.
Workup
- customThe product was purified by preparative TLC on silica plates
Sources & evidence
- ORD record
- ord-f0eafaa6302d42b989551ce08c285bbd
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08664200B2
Reaction notes
Loading…